Document is current
Any future updates will be listed below
-
Authors
Friedrich, Rhea https://orcid.org/0009-0007-1642-8764
Kernder, Anna
Blank, Norbert
Ernst, Diana https://orcid.org/0000-0003-0736-6243
Henes, Jörg
Keyßer, Gernot
Klemm, Philipp
Krusche, Martin https://orcid.org/0000-0002-0582-7790
Meinecke, Anna https://orcid.org/0009-0003-8517-616X
Rech, Jürgen
Schulz, Nils
Schomburg, Dirk
Vordenbäumen, Stefan
Feist, Eugen https://orcid.org/0000-0002-9872-5282
- License Information
-
More Information
Article History
Accepted: 5 November 2024
First Online: 12 December 2024
Declarations
:
: R. Friedrich declares that there is no conflict of interest. The study was funded by a DGRh scholarship (Maja-Völkel-Promotionsstipendium). A. Kernder received consulting/speaker fees from Chugai Pharma and Novartis. E. Feist received consulting/speaker fees from Abbvie, BMS, Celgene, Galapagos, Lilly, Medac, Novartis, Roche, Sanofi, Sobi, Pfizer, and UCB. S. Vordenbäumen received speaker fees from Sobi. J. Henes received consulting/speaker fees from Abbvie, BMS, GSK, Novartis, Roche, Sobi, Pfizer, and UCB. J. Rech received consulting/speaker fees from Abbvie, Biogen, BMS, Chugai, GSK, Janssen, Lilly, MSD, Novartis, Roche, Sanofi, Sobi, and UCB and a scientific grant from Novartis and Sobi. M. Krusche received consulting/speaker fees from Abbvie, BMS, Pfizer, Alphasigma, Lilly, Medac, Novartis, Roche, Sanofi, and Sobi. N. Blank, D. Ernst, G. Keyßer, P. Klemm, A. Meinecke, N. Schulz, and D. Schomburg declare that they have no competing interests.
: All procedures performed in studies involving human participants or on human tissue were in accordance with the ethical standards of the institutional and/or national research committee and with the 1975 Helsinki declaration and its later amendments or comparable ethical standards. Informed consent was obtained from all individual participants included in the study.
